ArticleProstate cancer and prostatic diseases2026
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer.
Autumn Gagnon et al.PubMed ↗Publisher ↗
No numbers read from the abstract.